Bethesda, MD
Core Facility
Collaborative
Established Technologies: CellMiner – Comprehensive molecular data on the NCI-60 cancer cell lines, including: Multiple microarray platforms measuring gene expression, Gene transcript level z score determination from 5 microarray platforms, aCGH DNA copy number, MicroRNA expression and Read More...
Frederick, MD
Collaborative
The Antibody Characterization Laboratory (ACL) is the laboratory responsible for the development of well-characterized monoclonal antibody reagents. The NCI’s Office of Cancer Clinical Proteomics Research funds ACL as a resource to the entire cancer Read More...